Serum testosterone elevation consistent with patient compliance with oral anti-androgen therapy for prostate cancer

被引：0
|
作者：
Davda, R. [1 ]
Khan, A. [1 ]
Dumas, L. [1 ]
Payne, H. [1 ]
机构：
[1] Univ Coll London Hosp NHS Trust, London, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2012年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
001
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [1] Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
    Zhang, Haozhe
    Zhou, Yi
    Xing, Zengzhen
    Sah, Rajiv Kumar
    Hu, Junqi
    Hu, Hailiang
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [2] Third generation anti-androgen therapy of advanced prostate cancer
    Ohlmann, C. -H.
    Kamradt, J.
    Stoeckle, M.
    [J]. UROLOGE, 2012, 51 (04): : 522 - 526
  • [3] Prevalence of osteoporosis in patients with prostate cancer on anti-androgen therapy
    Senan Sanz, M. R.
    Haro Iniesta, L.
    Riel Cabrera, R.
    Olive Ferre, F. X.
    Biel Arrufat, A.
    Matinero Romero, E.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 151S - 151S
  • [4] Anti-androgen monotherapy for metastatic prostate cancer
    Attard, Gerhardt
    [J]. LANCET ONCOLOGY, 2014, 15 (06): : 543 - 544
  • [5] Serum testosterone levels and testosterone 'bounce' phenomenon predict response to novel anti-androgen therapies in castration-resistant prostate cancer
    Tan, Yu Guang
    Quek, Sheriff Z. H.
    Huang, Hong Hong
    Ho, Henry S. S.
    Yuen, John S. P.
    Tay, Kae Jack
    Tuan, Jeffrey K. L.
    Chen, Kenneth
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (12) : 829.e9 - 829.e17
  • [6] EFFECTS OF ANTI-ANDROGEN THERAPY ON THE METASTATIC BEHAVIOR OF PROSTATE-CANCER
    HUTCHINS, GM
    DELAMONTE, SM
    MOORE, GW
    [J]. FEDERATION PROCEEDINGS, 1984, 43 (03) : 600 - 600
  • [7] Serum testosterone levels and testosterone 'bounce' phenomenon predict response to novel anti-androgen therapies in castration-resistant prostate cancer
    Tan, Y. G.
    Huang, H. H.
    Yuen, J. S.
    Tay, K. J.
    Tuan, J. K.
    Chen, K.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S1201 - S1201
  • [8] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    C Sanchez
    R Chan
    P Bajgain
    S Rambally
    G Palapattu
    M Mims
    C M Rooney
    A M Leen
    M K Brenner
    J F Vera
    [J]. Prostate Cancer and Prostatic Diseases, 2013, 16 : 123 - 131
  • [9] The genomic evolution of prostate cancer under the selective pressure of anti-androgen therapy
    Gsponer, Joel Roman
    Dietsche, Tanja
    Rufle, Alexander
    Lorber, Thomas
    Juskevicius, Darius
    Perrina, Valeria
    Lenkiewicz, Elisabeth
    Zellweger, Tobias
    Bachmann, Alexander
    Barrett, Michael T.
    Rentsch, Cyrill A.
    Ruiz, Christian
    Bubendorf, Lukas
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] Combining T-cell immunotherapy and anti-androgen therapy for prostate cancer
    Sanchez, C.
    Chan, R.
    Bajgain, P.
    Rambally, S.
    Palapattu, G.
    Mims, M.
    Rooney, C. M.
    Leen, A. M.
    Brenner, M. K.
    Vera, J. F.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) : 123 - 131
12345